Also trades as: CHM.AX (ASX) · $vol 0M
CHMMF OTC
Chimeric Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$11M
-48.0% ▼
Capital Expenditures
$11M
+0.0% ▲
5Y CAGR: +15.2%
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5M
-272.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$16M | -$26M | -$13M | -$10M | -$19M |
| Depreciation & Amort. | $950K | $965K | $0 | $1M | $0 |
| Stock-Based Comp. | $3M | $3M | $0 | $1M | $0 |
| Change in Working Capital | -$2M | $4M | $4M | -$214K | $0 |
| Other Non-Cash Items | $8M | $3M | $1M | $1M | $8M |
| Operating Cash Flow | -$13M | -$16M | -$8M | -$7M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | -$538K | -$112K | $0 | $0 | -$249K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$40K | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $13K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$565K | -$112K | $0 | $0 | -$249K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4M | -$2M | -$2M | $0 | -$898K |
| Stock Repurchased | -$1M | -$89K | -$1M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$10K | -$10K | $10M | -$914K |
| Financing Cash Flow | $10M | $253K | $8M | $10M | $6M |
| Net Change in Cash | -$4M | -$16M | $690K | $3M | -$5M |
| Cash End of Period | $18M | $2M | $3M | $6M | $799K |
| Free Cash Flow | -$14M | -$16M | -$8M | -$7M | $0 |